Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epi One
AddedMar 19, 2024
UpdatedJun 18, 2026
Epi One

Epi One

Revolutionary cancer diagnosis platform for early prognosis, detection, and drug response.

HQ
New York City, NY, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Epi One is developing a revolutionary cancer diagnosis platform aimed at addressing critical challenges in oncology. Their mission focuses on early cancer prognosis and detection, as well as predicting patient responses to post-diagnosis cancer treatments. The company's innovative approach seeks to transform cancer care by providing more accurate and timely diagnostic information to healthcare providers and patients.

Through their advanced platform, Epi One aims to improve cancer outcomes by enabling earlier interventions and more personalized treatment strategies. By integrating cutting-edge technologies and data analysis, the company strives to enhance the precision and effectiveness of cancer diagnosis and management, potentially leading to better patient care and survival rates in the field of oncology.

Epi One - Similar Companies

Epinoma logo

Epinoma

epinoma.com

Epic Sciences logo

Epic Sciences

epicsciences.com

Empiri logo

Empiri

empiricancer.com

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

Onko Solutions logo

Onko Solutions

Freenome logo

Freenome

freenome.com

OncoHealth logo

OncoHealth

oncohealthcorp.com

EcoGenome logo

EcoGenome

ecogenomellc.com

Oncodea logo

Oncodea

oncodea.com

OncoPrecision logo

OncoPrecision

oncoprecision.bio

Oncocyte logo

Oncocyte

oncocyte.com

Histofi logo

Histofi

histofi.com

Isabl logo

Isabl

isabl.io

Outcomes4Me logo

Outcomes4Me

Aeena Dx logo

Aeena Dx

Epi One - Quick Facts

Who are Epi One's competitors?

Companies similar to Epi One include Epinoma, Epic Sciences, Empiri and Episteme Prognostics.

When was Epi One founded?

Epi One was founded in 2016.

Where is Epi One's headquarters located?

Epi One's headquarters is located in New York City, NY, US.

When was Epi One's last funding round?

Epi One's most recent funding round was for $18.5M (USD) in December 2022.

How much has Epi One raised to-date?

As of Dec 27, 2022, Epi One has raised a total of $22.9M (USD).

How many employees does Epi One have?

Epi One has 36 employees as of Feb 5, 2024.

Epi One - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Cancer Diagnostics
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 24 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 513000Publishing Industries
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research